ABSTRACT
Chronic nicotine exposure increases sensitivity to nicotine reward during a withdrawal period, which may facilitate relapse in abstinent smokers, yet the molecular neuroadaptation(s) that contribute to this phenomenon are unknown. Interestingly, chronic nicotine use induces functional upregulation of nicotinic acetylcholine receptors (nAChRs) in the mesocorticolimbic reward pathway potentially linking upregulation to increased drug sensitivity. In the ventral tegmental area (VTA), functional upregulation of nAChRs containing the α4 subunit (α4* nAChRs) is restricted to GABAergic neurons. To test the hypothesis that increased functional expression of α4* nAChRs in these neurons modulates nicotine reward behaviors, we engineered a Cre recombinase-dependent gene expression system to selectively express α4 nAChR subunits harboring a "gain-of-function" mutation [a leucine mutated to a serine residue at the 9' position (Leu9'Ser)] in VTA GABAergic neurons of adult mice. In mice expressing Leu9'Ser α4 nAChR subunits in VTA GABAergic neurons (Gad2(VTA):Leu9'Ser mice), subreward threshold doses of nicotine were sufficient to selectively activate VTA GABAergic neurons and elicit acute hypolocomotion, with subsequent nicotine exposures eliciting tolerance to this effect, compared to control animals. In the conditioned place preference procedure, nicotine was sufficient to condition a significant place preference in Gad2(VTA):Leu9'Ser mice at low nicotine doses that failed to condition control animals. Together, these data indicate that functional upregulation of α4* nAChRs in VTA GABAergic neurons confers increased sensitivity to nicotine reward and points to nAChR subtypes specifically expressed in GABAergic VTA neurons as molecular targets for smoking cessation therapeutics.
Subject(s)
GABAergic Neurons/physiology , Nicotine/pharmacology , Nicotinic Agonists/pharmacology , Receptors, Nicotinic/metabolism , Reward , Up-Regulation/genetics , Ventral Tegmental Area/cytology , Action Potentials/drug effects , Action Potentials/genetics , Animals , Bacterial Proteins/genetics , Bacterial Proteins/metabolism , Calbindin 2/metabolism , Calbindins/metabolism , Conditioning, Operant/drug effects , Conditioning, Operant/physiology , Dihydro-beta-Erythroidine/pharmacology , Dose-Response Relationship, Drug , GABAergic Neurons/drug effects , Glutamate Decarboxylase/genetics , Luminescent Proteins/genetics , Luminescent Proteins/metabolism , Male , Mice , Mice, Inbred C57BL , Mice, Transgenic , Mutation/genetics , Proto-Oncogene Proteins c-fos/metabolism , Receptors, Nicotinic/genetics , Tyrosine 3-Monooxygenase/metabolism , Up-Regulation/drug effects , Ventral Tegmental Area/drug effectsABSTRACT
Nicotine binds to and activates a family of ligand-gated ion channels, neuronal nicotinic acetylcholine receptors (nAChRs). Chronic nicotine exposure alters the expression of various nAChR subtypes, which likely contributes to nicotine dependence; however, the underlying mechanisms regulating these changes remain unclear. A growing body of evidence indicates that microRNAs (miRNAs) may be involved in nAChR regulation. Using bioinformatics, miRNA library screening, site-directed mutagenesis, and gene expression analysis, we have identified a limited number of miRNAs that functionally interact with the 3'-untranslated regions (3' UTRs) of mammalian neuronal nAChR subunit genes. In silico analyses revealed specific, evolutionarily conserved sites within the 3' UTRs through which the miRNAs regulate gene expression. Mutating these sites disrupted miRNA regulation confirming the in silico predictions. In addition, the miRNAs that target nAChR 3' UTRs are expressed in mouse brain and are regulated by chronic nicotine exposure. Furthermore, we show that expression of one of these miRNAs, miR-542-3p, is modulated by nicotine within the mesocorticolimbic reward pathway. Importantly, overexpression of miR-542-3p led to a decrease in the protein levels of its target, the nAChR ß2 subunit. Bioinformatic analysis suggests that a number of the miRNAs play a general role in regulating cholinergic signaling. Our results provide evidence for a novel mode of nicotine-mediated regulation of the mammalian nAChR gene family.
Subject(s)
Ion Channels/biosynthesis , MicroRNAs/biosynthesis , Nicotine/metabolism , Receptors, Nicotinic/genetics , 3' Untranslated Regions , Animals , Brain/metabolism , Gene Expression Regulation/genetics , Ion Channels/genetics , Ligands , Mammals , Mice , MicroRNAs/genetics , Mutagenesis, Site-Directed , Organ Specificity , Receptors, Nicotinic/biosynthesis , Signal Transduction/geneticsABSTRACT
The type III RNAse, Dicer, is responsible for the processing of microRNA (miRNA) precursors into functional miRNA molecules, non-coding RNAs that bind to and target messenger RNAs for repression. Dicer expression is essential for mouse midbrain development and dopaminergic (DAergic) neuron maintenance and survival during the early post-natal period. However, the role of Dicer in adult mouse DAergic neuron maintenance and survival is unknown. To bridge this gap in knowledge, we selectively knocked-down Dicer expression in individual DAergic midbrain areas, including the ventral tegmental area (VTA) and substantia nigra pars compacta (SNpc) via viral-mediated expression of Cre in adult floxed Dicer knock-in mice (Dicer(flox/flox)). Bilateral Dicer loss in the VTA resulted in progressive hyperactivity that was significantly reduced by the dopamine agonist, amphetamine. In contrast, decreased Dicer expression in the SNpc did not affect locomotor activity but did induce motor-learning impairment on an accelerating rotarod. Knock-down of Dicer in both midbrain regions of adult Dicer(flox/flox) mice resulted in preferential, progressive loss of DAergic neurons likely explaining motor behavior phenotypes. In addition, knock-down of Dicer in midbrain areas triggered neuronal death via apoptosis. Together, these data indicate that Dicer expression and, as a consequence, miRNA function, are essential for DAergic neuronal maintenance and survival in adult midbrain DAergic neuron brain areas.
Subject(s)
DEAD-box RNA Helicases/metabolism , Dopaminergic Neurons/metabolism , Mesencephalon/metabolism , Ribonuclease III/metabolism , Amphetamine/pharmacology , Animals , Apoptosis , DEAD-box RNA Helicases/genetics , Dopamine Agonists/pharmacology , Dopaminergic Neurons/drug effects , Dopaminergic Neurons/physiology , Learning , Locomotion , Mesencephalon/cytology , Mesencephalon/growth & development , Mesencephalon/physiology , Mice , Organ Specificity , Phenotype , Ribonuclease III/geneticsABSTRACT
Little is known about chromosomal loopings involving proximal promoter and distal enhancer elements regulating GABAergic gene expression, including changes in schizophrenia and other psychiatric conditions linked to altered inhibition. Here, we map in human chromosome 2q31 the 3D configuration of 200 kb of linear sequence encompassing the GAD1 GABA synthesis enzyme gene locus, and we describe a loop formation involving the GAD1 transcription start site and intergenic noncoding DNA elements facilitating reporter gene expression. The GAD1-TSS(-50kbLoop) was enriched with nucleosomes epigenetically decorated with the transcriptional mark, histone H3 trimethylated at lysine 4, and was weak or absent in skin fibroblasts and pluripotent stem cells compared with neuronal cultures differentiated from them. In the prefrontal cortex of subjects with schizophrenia, GAD1-TSS(-50kbLoop) was decreased compared with controls, in conjunction with downregulated GAD1 expression. We generated transgenic mice expressing Gad2 promoter-driven green fluorescent protein-conjugated histone H2B and confirmed that Gad1-TSS(-55kbLoop), the murine homolog to GAD1-TSS(-50kbLoop), is a chromosomal conformation specific for GABAergic neurons. In primary neuronal culture, Gad1-TSS(-55kbLoop) and Gad1 expression became upregulated when neuronal activity was increased. We conclude that 3D genome architectures, including chromosomal loopings for promoter-enhancer interactions involved in the regulation of GABAergic gene expression, are conserved between the rodent and primate brain, and subject to developmental and activity-dependent regulation, and disordered in some cases with schizophrenia. More broadly, the findings presented here draw a connection between noncoding DNA, spatial genome architecture, and neuronal plasticity in development and disease.
Subject(s)
Glutamate Decarboxylase/genetics , Prefrontal Cortex/metabolism , Schizophrenia/genetics , Animals , Antipsychotic Agents/pharmacology , Cells, Cultured , Chromosomes, Human, Pair 2 , Clozapine/pharmacology , DNA Methylation , Down-Regulation , Fibroblasts/metabolism , Gene Expression Regulation , Glutamate Decarboxylase/metabolism , Haloperidol/pharmacology , Hippocampus/drug effects , Hippocampus/metabolism , Histones/genetics , Histones/metabolism , Humans , Mice , Mice, Transgenic , Neurons/drug effects , Neurons/metabolism , Schizophrenia/metabolismABSTRACT
The growing threat of an influenza pandemic presents a unique challenge to healthcare workers, emergency responders, and the civilian population. The Occupational Safety and Health Administration (OSHA) recommends National Institute for Occupational Safety and Health (NIOSH)-approved respirators to provide protection against infectious airborne viruses in various workplace settings. The filtration efficiency of selected NIOSH-approved particulate N95 and P100 filtering facepiece respirators (FFRs) and filter cartridges was investigated against the viable MS2 virus, a non-pathogenic bacteriophage, aerosolized from a liquid suspension. Tests were performed under two cyclic flow conditions (minute volumes of 85 and 135 L/min) and two constant flow rates (85 and 270 L/min). The mean penetrations of viable MS2 through the N95 and P100 FFRs/cartridges were typically less than 2 and 0.03%, respectively, under all flow conditions. All N95 and P100 FFR and cartridge models assessed in this study, therefore, met or exceeded their respective efficiency ratings of 95 and 99.97% against the viable MS2 test aerosol, even under the very high flow conditions. These NIOSH-approved FFRs and particulate respirators equipped with these cartridges can be anticipated to achieve expected levels of protection (consistent with their assigned protection factor) against airborne viral agents, provided that they are properly selected, fitted, worn, and maintained.
Subject(s)
Air Microbiology , Inhalation Exposure/prevention & control , Respiratory Protective Devices , Air Movements , Analysis of Variance , Filtration , Humans , Influenza A virus , Influenza, Human/prevention & control , Materials Testing , National Institute for Occupational Safety and Health, U.S. , Occupational Exposure/prevention & control , Particle Size , United StatesABSTRACT
Nicotine is reinforcing because it activates dopaminergic (DAergic) neurons within the ventral tegmental area (VTA) of the brain's mesocorticolimbic reward circuitry. This increase in activity can occur for a period of several minutes up to an hour and is thought to be a critical component of nicotine dependence. However, nicotine concentrations that are routinely self-administered by smokers are predicted to desensitize high-affinity α4ß2 neuronal nicotinic acetylcholine receptors (nAChRs) in seconds. Thus, how physiologically relevant nicotine concentrations persistently activate VTA DAergic neurons is unknown. Here we show that nicotine can directly and robustly increase the firing frequency of VTA DAergic neurons for several minutes. In mouse midbrain slices, 300 nM nicotine elicited a persistent inward current in VTA DAergic neurons that was blocked by α-conotoxin MII[H9A;L15A], a selective antagonist of nAChRs containing the α6 subunit. α-conotoxin MII[H9A;L15A] also significantly reduced the long-lasting increase in DAergic neuronal activity produced by low concentrations of nicotine. In addition, nicotine failed to significantly activate VTA DAergic neurons in mice that did not express either α4 or α6 nAChR subunits. Conversely, selective activation of nAChRs containing the α4 subunit in knock-in mice expressing a hypersensitive version of these receptors yielded a biphasic response to nicotine consisting of an acute desensitizing increase in firing frequency followed by a sustained increase that lasted several minutes and was sensitive to α-conotoxin MII[H9A;L15A]. These data indicate that nicotine persistently activates VTA DAergic neurons via nAChRs containing α4 and α6 subunits.
Subject(s)
Dopamine/metabolism , Neurons/drug effects , Nicotine/pharmacology , Receptors, Nicotinic/metabolism , Ventral Tegmental Area/drug effects , Animals , Mice , Mice, Inbred C57BL , Neurons/metabolism , Receptors, Nicotinic/chemistry , Ventral Tegmental Area/cytology , Ventral Tegmental Area/metabolismABSTRACT
Recently, the smoking cessation therapeutic varenicline, a nicotinic acetylcholine receptor (nAChR) partial agonist, has been shown to reduce alcohol consumption. However, the mechanism and nAChR subtype(s) involved are unknown. Here we demonstrate that varenicline and alcohol exposure, either alone or in combination, selectively activates dopaminergic (DAergic) neurons within the posterior, but not the anterior, ventral tegmental area (VTA). To gain insight into which nAChR subtypes may be involved in the response to alcohol, we analyzed nAChR subunit gene expression in posterior VTA DAergic neurons. Ethanol-activated DAergic neurons expressed higher levels of alpha4, alpha6, and beta3 subunit genes compared with nonactivated neurons. To examine the role of nicotinic receptors containing the alpha4 subunit (alpha4* nAChRs) in varenicline-induced reduction of alcohol consumption, we examined the effect of the drug in two complementary mouse models, a knock-out line that does not express the alpha4 subunit (alpha4 KO) and another line that expresses alpha4* nAChRs hypersensitive to agonist (Leu9'Ala). While varenicline (0.1-0.3 mg/kg, i.p.) reduced 2% and 20% alcohol consumption in wild-type (WT) mice, the drug did not significantly reduce consumption in alpha4 KO animals. Conversely, low doses of varenicline (0.0125-0.05 mg/kg, i.p.) that had little effect in WT mice dramatically reduced ethanol intake in Leu9'Ala mice. Infusion of varenicline into the posterior, but not the anterior VTA was sufficient to reduce alcohol consumption. Together, our data indicate that activation of alpha4* nAChRs is necessary and sufficient for varenicline reduction of alcohol consumption.
Subject(s)
Alcohol Drinking/drug therapy , Benzazepines/therapeutic use , Nicotinic Agonists/therapeutic use , Quinoxalines/therapeutic use , Receptors, Nicotinic/metabolism , Alanine/genetics , Alcohol Drinking/genetics , Alcohol Drinking/pathology , Analysis of Variance , Animals , Central Nervous System Depressants/administration & dosage , Disease Models, Animal , Dopamine/metabolism , Dose-Response Relationship, Drug , Drinking Behavior/drug effects , Drinking Behavior/physiology , Drug Combinations , Ethanol/administration & dosage , Gene Expression Regulation/drug effects , Gene Expression Regulation/genetics , Leucine/genetics , Male , Mice , Mice, Inbred C57BL , Mice, Transgenic , Mutation/genetics , Neurons/drug effects , Neurons/metabolism , Proto-Oncogene Proteins c-fos/metabolism , Receptors, Nicotinic/deficiency , Tyrosine 3-Monooxygenase/metabolism , Varenicline , Ventral Tegmental Area/cytology , Ventral Tegmental Area/drug effectsABSTRACT
Recent studies suggest that high-affinity neuronal nicotinic acetylcholine receptors (nAChRs) containing alpha4 and beta2 subunits (alpha4beta2*) functionally interact with G-protein-coupled dopamine (DA) D(2) receptors in basal ganglia. We hypothesized that if a functional interaction between these receptors exists, then mice expressing an M2 point mutation (Leu9'Ala) rendering alpha4 nAChRs hypersensitive to ACh may exhibit altered sensitivity to a D(2)-receptor agonist. When challenged with the D(2)R agonist, quinpirole (0.5-10 mg/kg), Leu9'Ala mice, but not wild-type (WT) littermates, developed severe, reversible motor impairment characterized by rigidity, catalepsy, akinesia, and tremor. While striatal DA tissue content, baseline release, and quinpirole-induced DA depletion did not differ between Leu9'Ala and WT mice, quinpirole dramatically increased activity of cholinergic striatal interneurons only in mutant animals, as measured by increased c-Fos expression in choline acetyltransferase (ChAT)-positive interneurons. Highlighting the importance of the cholinergic system in this mouse model, inhibiting the effects of ACh by blocking muscarinic receptors, or by selectively activating hypersensitive nAChRs with nicotine, rescued motor symptoms. This novel mouse model mimics the imbalance between striatal DA/ACh function associated with severe motor impairment in disorders such as Parkinson's disease, and the data suggest that a D(2)R-alpha4*-nAChR functional interaction regulates cholinergic interneuron activity.
Subject(s)
Parkinsonian Disorders/etiology , Receptors, Dopamine D2/metabolism , Receptors, Nicotinic/physiology , Acetylcholine/physiology , Amino Acid Substitution , Animals , Catalepsy/etiology , Cholinergic Fibers/drug effects , Cholinergic Fibers/physiology , Dopamine Agonists/pharmacology , Epilepsy, Generalized/etiology , Female , Interneurons/drug effects , Interneurons/physiology , Male , Mice , Mice, Inbred C57BL , Mice, Mutant Strains , Muscle Rigidity/etiology , Mutagenesis, Site-Directed , Parkinsonian Disorders/genetics , Parkinsonian Disorders/physiopathology , Quinpirole/pharmacology , Receptors, Nicotinic/chemistry , Receptors, Nicotinic/genetics , Recombinant Proteins/chemistry , Recombinant Proteins/genetics , Recombinant Proteins/metabolism , Tremor/etiologyABSTRACT
Tobacco use is the leading preventable cause of mortality in the world. The limited number of smoking cessation aids currently available are minimally effective, highlighting the need for novel therapeutic interventions. We describe a genome-wide approach to identify potential candidates for such interventions. Next-generation sequencing was performed using RNA isolated from the habenulo-interpeduncular circuit of male mice withdrawn from chronic nicotine treatment. This circuit plays a central role in the nicotine withdrawal response. Differentially expressed miRNAs and mRNAs were validated using RT-qPCR. Many of the differentially expressed mRNAs are predicted targets of reciprocally expressed miRNAs. We illustrate the utility of the dataset by demonstrating that knockdown in the interpeduncular nucleus of a differentially expressed mRNA, that encoding profilin 2, is sufficient to induce anxiety-related behavior. Importantly, profilin 2 knockdown in the ventral tegmental area did not affect anxiety behavior. Our data reveal wide-spread changes in gene expression within the habenulo-interpeduncular circuit during nicotine withdrawal. This dataset should prove to be a valuable resource leading to the identification of substrates for the design of innovative smoking cessation aids.
Subject(s)
Habenula/physiology , Interpeduncular Nucleus/physiology , MicroRNAs/genetics , Nicotine , RNA, Messenger/genetics , Substance Withdrawal Syndrome/genetics , Animals , Anxiety/genetics , Gene Expression Profiling , Gene Knockdown Techniques , Male , Mice, Inbred C57BL , Profilins/geneticsABSTRACT
BACKGROUND: Dopamine (DA) is hypothesized to modulate anxiety-like behavior, although the precise role of DA in anxiety behaviors and the complete anxiety network in the brain have yet to be elucidated. Recent data indicate that dopaminergic projections from the ventral tegmental area (VTA) innervate the interpeduncular nucleus (IPN), but how the IPN responds to DA and what role this circuit plays in anxiety-like behavior are unknown. METHODS: We expressed a genetically encoded G protein-coupled receptor activation-based DA sensor in mouse midbrain to detect DA in IPN slices using fluorescence imaging combined with pharmacology. Next, we selectively inhibited or activated VTAâIPN DAergic inputs via optogenetics during anxiety-like behavior. We used a biophysical approach to characterize DA effects on neural IPN circuits. Site-directed pharmacology was used to test if DA receptors in the IPN can regulate anxiety-like behavior. RESULTS: DA was detected in mouse IPN slices. Silencing/activating VTAâIPN DAergic inputs oppositely modulated anxiety-like behavior. Two neuronal populations in the ventral IPN (vIPN) responded to DA via D1 receptors (D1Rs). vIPN neurons were controlled by a small population of D1R neurons in the caudal IPN that directly respond to VTA DAergic terminal stimulation and innervate the vIPN. IPN infusion of a D1R agonist and antagonist bidirectionally controlled anxiety-like behavior. CONCLUSIONS: VTA DA engages D1R-expressing neurons in the caudal IPN that innervate vIPN, thereby amplifying the VTA DA signal to modulate anxiety-like behavior. These data identify a DAergic circuit that mediates anxiety-like behavior through unique IPN microcircuitry.
Subject(s)
Dopamine , Interpeduncular Nucleus , Animals , Anxiety , Dopaminergic Neurons , Mesencephalon , Mice , Ventral Tegmental AreaABSTRACT
This study investigated the effect of high flow conditions on aerosol penetration and the relationship between penetration at constant and cyclic flow conditions. National Institute for Occupational Safety and Health (NIOSH)-approved N95 and P100 filtering facepiece respirators and cartridges were challenged with inert solid and oil aerosols. A combination of monodisperse aerosol and size-specific aerosol measurement equipment allowed count-based penetration measurement of particles with nominal diameters ranging from 0.02 to 2.9 microm. Three constant flow conditions (85, 270, and 360 L/min) were selected to match the minute, inhalation mean, and inhalation peak flows of the four cyclic flow conditions (40, 85, 115, and 135 L/min) tested. As expected, penetration was found to increase under increased constant and cyclic flow conditions. The most penetrating particle size (MPPS) generally ranged from 0.05 to 0.2 microm for P100 filters and was approximately 0.05 microm for N95 filters. Although penetration increased at the high flow conditions, the MPPS was relatively unaffected by flow. Of the constant flows tested, the flows equivalent to cyclic inhalation mean and peak flows best approximated the penetration measurements of the corresponding cyclic flows.
Subject(s)
Air Pollutants/analysis , Filtration/instrumentation , Inhalation Exposure/analysis , Respiratory Protective Devices/standards , Materials Testing/instrumentation , Materials Testing/methods , National Institute for Occupational Safety and Health, U.S. , Particle Size , United StatesABSTRACT
BACKGROUND: Members of the NET subfamily of zinc-finger proteins are related to the Sp-family of transcription factors and are required during embryogenesis. In particular, Nlz1/Znf703 and Nlz2/Znf503 are required for formation of rhombomere 4 of the vertebrate hindbrain. While NET family proteins have been hypothesized to regulate transcription, it remains unclear if they function as activators or repressors of transcription. RESULTS: Here we demonstrate that Nlz proteins repress transcription both in cell lines and in developing zebrafish embryos. We first use standard cell culture-based reporter assays to demonstrate that Nlz1/Znf703 represses transcription of a luciferase reporter in four different cell lines. Structure-function analyses and pharmacological inhibition further reveal that Nlz1-mediated repression requires histone deacetylase activity. We next generate a stable transgenic zebrafish reporter line to demonstrate that Nlz1 promotes histone deacetylation at the transgenic promoter and repression of transgene expression during embryogenesis. Lastly, taking a genetic approach we find that endogenous Nlz proteins are required for formation of hindbrain rhombomere 4 during zebrafish embryogenesis by repressing expression of non-rhombomere 4 genes. CONCLUSION: We conclude that Nlz1/Znf703 acts as a repressor of transcription and hypothesize that other NET family members function in a similar manner.
Subject(s)
DNA-Binding Proteins/metabolism , Repressor Proteins/metabolism , Transcription, Genetic , Zebrafish Proteins/metabolism , Animals , Binding Sites , DNA-Binding Proteins/genetics , Embryo, Mammalian/metabolism , HeLa Cells , Histone Deacetylases/genetics , Histone Deacetylases/metabolism , Humans , Mice , NIH 3T3 Cells , Protein Structure, Tertiary , Repressor Proteins/genetics , Transfection , Transgenes , Zebrafish/embryology , Zebrafish/genetics , Zebrafish/metabolism , Zebrafish Proteins/genetics , Zinc Fingers/geneticsABSTRACT
Nicotinic acetylcholine receptors are involved in a plethora of fundamental biological processes ranging from muscle contraction to formation of memories. The receptors are pentameric proteins whose subunits are encoded by distinct genes. Subunit composition of a mature nicotinic receptor is governed in part by the transcriptional regulation of each subunit gene. Here, using chromatin immunoprecipitation assays, we report the interaction of the transcription factors Sp1, Sp3, c-Jun and Sox10 with the beta4 subunit gene promoter in neuronal-like cell lines and rodent brain tissue. Our results corroborate previous in-vitro data demonstrating that these transcription factors interact with the beta4 promoter. Taken together, these data suggest that Sp1, Sp3, c-Jun and Sox10 regulate expression of the beta4 subunit gene in the mammalian brain.
Subject(s)
Brain/physiology , Gene Expression Regulation , Promoter Regions, Genetic/genetics , Receptors, Nicotinic/genetics , Transcription Factors/genetics , Animals , Blotting, Northern , Blotting, Western , Cell Line , Immunoprecipitation , Mice , Neurons/physiology , Oligonucleotide Array Sequence Analysis , Polymerase Chain Reaction , Rats , Transcription, GeneticABSTRACT
Novelty preference (NP) is an evolutionarily conserved, essential survival mechanism often dysregulated in neuropsychiatric disorders. NP is mediated by a motivational dopamine signal that increases in response to novel stimuli, thereby driving exploration. However, the mechanism by which once-novel stimuli transition to familiar stimuli is unknown. Here we describe a neuroanatomical substrate for familiarity signaling, the interpeduncular nucleus (IPN) of the midbrain, which is activated as novel stimuli become familiar with multiple exposures. In mice, optogenetic silencing of IPN neurons increases salience of and interaction with familiar stimuli without affecting novelty responses, whereas photoactivation of the same neurons reduces exploration of novel stimuli mimicking familiarity. Bidirectional control of NP by the IPN depends on familiarity signals and novelty signals arising from excitatory habenula and dopaminergic ventral tegmentum inputs, which activate and reduce IPN activity, respectively. These results demonstrate that familiarity signals through unique IPN circuitry that opposes novelty seeking to control NP.
Subject(s)
Choice Behavior/physiology , Exploratory Behavior/physiology , Interpeduncular Nucleus/physiology , Nerve Net/physiology , Recognition, Psychology/physiology , Signal Transduction/physiology , Animals , Choice Behavior/drug effects , Dopamine Antagonists/pharmacology , Exploratory Behavior/drug effects , Interpeduncular Nucleus/drug effects , Male , Maze Learning/drug effects , Maze Learning/physiology , Mice , Mice, Inbred C57BL , Mice, Transgenic , Nerve Net/drug effects , Optogenetics/methods , Organ Culture Techniques , Recognition, Psychology/drug effects , Signal Transduction/drug effectsABSTRACT
Paternal environmental conditions can influence phenotypes in future generations, but it is unclear whether offspring phenotypes represent specific responses to particular aspects of the paternal exposure history, or a generic response to paternal 'quality of life'. Here, we establish a paternal effect model based on nicotine exposure in mice, enabling pharmacological interrogation of the specificity of the offspring response. Paternal exposure to nicotine prior to reproduction induced a broad protective response to multiple xenobiotics in male offspring. This effect manifested as increased survival following injection of toxic levels of either nicotine or cocaine, accompanied by hepatic upregulation of xenobiotic processing genes, and enhanced drug clearance. Surprisingly, this protective effect could also be induced by a nicotinic receptor antagonist, suggesting that xenobiotic exposure, rather than nicotinic receptor signaling, is responsible for programming offspring drug resistance. Thus, paternal drug exposure induces a protective phenotype in offspring by enhancing metabolic tolerance to xenobiotics.
Subject(s)
Environmental Exposure , Nicotine/metabolism , Nicotinic Agonists/metabolism , Paternal Exposure , Paternal Inheritance , Xenobiotics/metabolism , Animals , Drug Resistance , Female , Inactivation, Metabolic , Liver/metabolism , Male , Mice , Survival AnalysisABSTRACT
Heterogeneous nuclear ribonucleoprotein K (hnRNP K) was originally identified as being part of the hnRNP particle. hnRNP K has subsequently been shown to be involved in a number of fundamental biological processes such as RNA transport and processing as well as transcription and translation. In addition, hnRNP K is an integral player in a variety of intracellular signal transduction pathways. Not surprisingly given this broad array of cellular functions, hnRNP K is a highly interactive protein binding directly to both single- and double-stranded nucleic acids as well as numerous signaling proteins. Interestingly, earlier studies demonstrated that hnRNP K protein is not ubiquitously expressed and does not exist in a fixed stoichiometry with other hnRNP proteins. We have extended this earlier work and report here the spatially- and developmentally-regulated expression of hnRNP K mRNA during development of the rat nervous system. In the central nervous system, hnRNP K mRNA expression gradually decreases during development until it is restricted to a very limited number of structures including most notably the hippocampus and the retina. Immunohistochemical data indicate that hnRNP K protein expression closely parallels hnRNP K mRNA expression. In contrast to the central nervous system, hnRNP K in the peripheral nervous system remains high throughout embryonic development with dramatic expression in several peripheral ganglia.
Subject(s)
Central Nervous System/embryology , Central Nervous System/metabolism , Heterogeneous-Nuclear Ribonucleoprotein K/genetics , Animals , Female , Heterogeneous-Nuclear Ribonucleoprotein K/metabolism , Hippocampus/embryology , Hippocampus/metabolism , Immunohistochemistry , Organ Specificity , Peripheral Nervous System/embryology , Peripheral Nervous System/metabolism , RNA, Messenger/analysis , Rats , Rats, Sprague-Dawley , Retina/embryology , Retina/metabolismABSTRACT
Cocaine addiction and depression are comorbid disorders. Although it is well recognized that 5-hydroxytryptamine (5-HT; serotonin) plays a central role in depression, our understanding of its role in addiction is notably lacking. The 5-HT system in the brain is carefully controlled by a combined process of regulating 5-HT neuron firing through 5-HT autoreceptors, neurotransmitter release, enzymatic degradation, and reuptake by transporters. This study tests the hypothesis that activation of 5-HT1A autoreceptors, which would lessen 5-HT neuron firing, contributes to cocaine-seeking behaviors. Using 5-HT neuron-specific reduction of 5-HT1A autoreceptor gene expression in mice, we demonstrate that 5-HT1A autoreceptors are necessary for cocaine conditioned place preference. In addition, using designer receptors exclusively activated by designer drugs (DREADDs) technology, we found that stimulation of the serotonergic dorsal raphe nucleus (DRN) afferents to the nucleus accumbens (NAc) abolishes cocaine reward and promotes antidepressive-like behaviors. Finally, using a rat model of compulsive-like cocaine self-administration, we found that inhibition of dorsal raphe 5-HT1A autoreceptors attenuates cocaine self-administration in rats with 6 h extended access, but not 1 h access to the drug. Therefore, our findings suggest an important role for 5-HT1A autoreceptors, and thus DRNî²NAc 5-HT neuronal activity, in the etiology and vulnerability to cocaine reward and addiction. Moreover, our findings support a strategy for antagonizing 5-HT1A autoreceptors for treating cocaine addiction.
Subject(s)
Cocaine/administration & dosage , Compulsive Behavior/physiopathology , Dorsal Raphe Nucleus/physiopathology , Drug-Seeking Behavior/physiology , Receptor, Serotonin, 5-HT1A/physiology , Serotonergic Neurons/physiology , Animals , Autoreceptors/antagonists & inhibitors , Autoreceptors/physiology , Conditioning, Classical/drug effects , Conditioning, Classical/physiology , Designer Drugs/administration & dosage , Dorsal Raphe Nucleus/drug effects , Drug-Seeking Behavior/drug effects , Gene Knockdown Techniques , Male , Mice , Motivation/drug effects , Motivation/physiology , Neural Pathways/drug effects , Neural Pathways/physiopathology , Nucleus Accumbens/drug effects , Nucleus Accumbens/physiopathology , Rats , Rats, Wistar , Receptor, Serotonin, 5-HT1A/genetics , Reward , Serotonergic Neurons/drug effects , Serotonin 5-HT1 Receptor Antagonists/administration & dosageABSTRACT
Cholinergic neurons in the medial habenula (MHb) modulate anxiety during nicotine withdrawal although the molecular neuroadaptation(s) within the MHb that induce affective behaviors during nicotine cessation is largely unknown. MHb cholinergic neurons are unique in that they robustly express neuronal nicotinic acetylcholine receptors (nAChRs), although their behavioral role as autoreceptors in these neurons has not been described. To test the hypothesis that nAChR signaling in MHb cholinergic neurons could modulate anxiety, we expressed novel "gain of function" nAChR subunits selectively in MHb cholinergic neurons of adult mice. Mice expressing these mutant nAChRs exhibited increased anxiety-like behavior that was alleviated by blockade with a nAChR antagonist. To test the hypothesis that anxiety induced by nicotine withdrawal may be mediated by increased MHb nicotinic receptor signaling, we infused nAChR subtype selective antagonists into the MHb of nicotine naïve and withdrawn mice. While antagonists had little effect on nicotine naïve mice, blocking α4ß2 or α6ß2, but not α3ß4 nAChRs in the MHb alleviated anxiety in mice undergoing nicotine withdrawal. Consistent with behavioral results, there was increased functional expression of nAChRs containing the α6 subunit in MHb neurons that also expressed the α4 subunit. Together, these data indicate that MHb cholinergic neurons regulate nicotine withdrawal-induced anxiety via increased signaling through nicotinic receptors containing the α6 subunit and point toward nAChRs in MHb cholinergic neurons as molecular targets for smoking cessation therapeutics.
Subject(s)
Anxiety/metabolism , Cholinergic Neurons/metabolism , Habenula/metabolism , Nicotine/adverse effects , Receptors, Nicotinic/biosynthesis , Substance Withdrawal Syndrome/metabolism , Animals , Anxiety/psychology , Cholinergic Neurons/drug effects , Habenula/drug effects , Male , Mice , Mice, Inbred C57BL , Mice, Knockout , Nicotinic Agonists/pharmacology , Substance Withdrawal Syndrome/psychologyABSTRACT
Increased anxiety is a prominent withdrawal symptom in abstinent smokers, yet the neuroanatomical and molecular bases underlying it are unclear. Here we show that withdrawal-induced anxiety increases activity of neurons in the interpeduncular intermediate (IPI), a subregion of the interpeduncular nucleus (IPN). IPI activation during nicotine withdrawal was mediated by increased corticotropin releasing factor (CRF) receptor-1 expression and signalling, which modulated glutamatergic input from the medial habenula (MHb). Pharmacological blockade of IPN CRF1 receptors or optogenetic silencing of MHb input reduced IPI activation and alleviated withdrawal-induced anxiety; whereas IPN CRF infusion in mice increased anxiety. We identified a mesointerpeduncular circuit, consisting of ventral tegmental area (VTA) dopaminergic neurons projecting to the IPN, as a potential source of CRF. Knockdown of CRF synthesis in the VTA prevented IPI activation and anxiety during nicotine withdrawal. These data indicate that increased CRF receptor signalling within a VTA-IPN-MHb circuit triggers anxiety during nicotine withdrawal.
Subject(s)
Anxiety/etiology , Corticotropin-Releasing Hormone/metabolism , Habenula/physiology , Interpeduncular Nucleus/physiology , Nicotine/adverse effects , Ventral Tegmental Area/physiology , Animals , Habenula/anatomy & histology , Male , Mice , Mice, Inbred C57BL , Nerve Net , Receptors, Corticotropin-Releasing Hormone/genetics , Receptors, Corticotropin-Releasing Hormone/metabolism , Signal Transduction/physiology , Substance Withdrawal Syndrome/physiopathologyABSTRACT
Paternal diet can impact metabolic phenotypes in offspring, but mechanisms underlying such intergenerational information transfer remain obscure. Here, we interrogate cytosine methylation patterns in sperm obtained from mice consuming one of three diets, generating whole genome methylation maps for four pools of sperm samples and for 12 individual sperm samples, as well as 61 genome-scale methylation maps. We find that "epivariation," either stochastic or due to unknown demographic or environmental factors, was a far stronger contributor to the sperm methylome than was the diet consumed. Variation in cytosine methylation was particularly dramatic over tandem repeat families, including ribosomal DNA (rDNA) repeats, but rDNA methylation was strongly correlated with genetic variation in rDNA copy number and was not influenced by paternal diet. These results identify loci of genetic and epigenetic lability in the mammalian genome but argue against a direct role for sperm cytosine methylation in dietary reprogramming of offspring metabolism.